Back to search

Article

Lipid-mediated insertion of Toll-like receptor (TLR) ligands for facile immune cell engineering

2019-11-16

Abstract excerpt

Cell-based immunotherapies have tremendous potential to treat many diseases, such as activating immunity in cancer or suppressing it in autoimmune diseases. Most cell-based cancer immunotherapies in the clinic provide adjuvant signals through genetic engineering to enhance T cell functions. However, genetically encoded signals have minimal control over dosing and persist for the life of a cell lineage. These prope...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e1e62145-6277-540e-ae8c-263ae3a18810
DOI
10.1101/840876
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Lipid-mediated insertion of Toll-like receptor (TLR) ligands for facile immune cell engineeringDOI 10.1101/840876
Select a neighboring publication to make it the new centre.